During the past decade, Alaska Urological Institute dba Alaska Clinical Research Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alaska Urological Institute dba Alaska Clinical Research Center" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Allergan" with 1 trials sponsored, "Anchiano Therapeutics Israel Ltd." with 1 trials sponsored and "Astellas Pharma Global Development, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alaska Urological Institute dba Alaska Clinical Research Center" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Seagen Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Alaska Urological Institute dba Alaska Clinical Research Center" are "Urothelial Cancer" (4 trials), "Carcinoma, Transitional Cell" (2 trials), "Renal Pelvis Neoplasms" (2 trials), "Ureteral Neoplasms" (2 trials) and "Urethral Neoplasms" (2 trials). Many other conditions were trialed in "Alaska Urological Institute dba Alaska Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Alaska Urological Institute dba Alaska Clinical Research Center" are "Drug" (12 trials), "Biological" (3 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (3 trials), "Enzalutamide" (2 trials), "Ipilimumab" (2 trials), "Placebo" (2 trials) and "Abiraterone/Prednisone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alaska Urological Institute dba Alaska Clinical Research Center" are 11 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Alaska Urological Institute dba Alaska Clinical Research Center". undefined are not yet recruiting, 2 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Alaska Urological Institute dba Alaska Clinical Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Alaska Urological Institute dba Alaska Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".